Many of the cancer-related mutations are associated with breast and/or ovarian cancer, and map to BRCA1, BRCA2 and their associated proteins involved in processes related to DNA synthesis and repair (e.g. CHEK2, BARD1, BRIP1 and TP53). The gene discussed is TP53; the disease is ovarian cancer.